Beyond five years: Long-term follow-up in pediatric liver transplantation

Current Gastroenterology Reports

Volumn 9, Issue 3, 2007, Pages 230-236

  Treem, William R ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; RECOMBINANT GROWTH HORMONE; TACROLIMUS;

ABSENCE OF SIDE EFFECTS; BILE DUCT ATRESIA; BILIARY TRACT DISEASE; BONE DENSITY; CATCH UP GROWTH; CHILD; COGNITION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EARLY DIAGNOSIS; FOLLOW UP; GRAFT DYSFUNCTION; GRAFT SURVIVAL; GROWTH RETARDATION; HEPATITIS; HUMAN; HYPERTENSION; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LIVER CANCER; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LONG TERM CARE; NEPHROTOXICITY; OSTEOPENIA; OSTEOPOROSIS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PEDIATRIC SURGERY; QUALITY OF LIFE; REVIEW; SCOLIOSIS; SURVIVAL RATE; VASCULAR DISEASE;

ADOLESCENT; CHILD; CHILD DEVELOPMENT; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; QUALITY OF LIFE; SURVIVAL ANALYSIS; SURVIVORS; TIME FACTORS;

EID: 34249871925     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-007-0024-1     Document Type: Review

References (50)

1. Calne RY, Rolles K, White DJG, et al.: Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases and 2 livers. Lancet 1979, 2:1033-1036.
2. Muiesan P, Vergani D, Mieli-Vergani G: Liver transplantation in children. J Hepatol 2007, 46:340-348.
3. Busuttil R, Farmer D, Yersiz H, et al.: Analysis of long-term outcomes of 3200 liver transplantations over two decades. Ann Surg 2005, 241:905-916.
4. Goss J, Shackleton C, McDiarmid S, et al.: Long-term results of pediatric liver transplantation: an analysis of 569 transplants. Ann Surg 1998, 228:411-420.
5. Fouquet V, Alves A, Branchereau S, et al.: Long-term outcome of pediatric liver transplantation for biliary atresia: a 10-year follow-up in a single center. Liver Transpl 2005, 11:152-160.
6. Diem HV, Evrard V, Vinh HT, et al.: Pediatric liver transplantation for biliary atesia: results of primary grafts in 328 recipients. Transplantation 2003, 75:1692-1697.
7. Jain A, Marcos A, Reyes J, et al.: Tacrolimus for primary liver transplantation: 12-15 years actual follow-up with safety profile. Transplant Proc 2005, 37:1207-1210.
8. Austin MT, Leys CM, Feurer ID, et al.: Liver transplantation for childhood hepatic malignancy: a review of the United Network for Organ sharing (UNOS) database. J Pediatr Surg 2006, 41:182-186.
9. McDiarmid S, Gombein J, DeSilva P, et al.: Factors affecting growth after pediatric liver transplantation. Transplantation 1999, 67:404-411.
10. Renz J, de Roos M, Rosenthal P, et al.: Posttransplantation growth in pediatric liver recipients. Liver Transpl 2001, 7:1040-1055.
11. Park SJ, Rim SH, Kyung MK, et al.: Long-term growth of pediatric patients following living-donor liver transplantation. J Korean Med Sci 2005; 20:835-840.
12. Bartosh S, Thomas S, Sutton M, et al.: Linear growth after pediatric liver transplantation. J Pediatr 1999, 135:624-631.
13. Orii T, Ohkohchi N, Koyamada N, et al.: Growth of pediatric patients with biliary atresia after liver transplantation: influence of age at transplantation and steroid administration. Transplant Proc 2000; 32:2210-2212.
14. Lopez-Espinosa J, Yeste-Fernandez D, Iglesias-Berengue J, et al.: Factors affecting catch-up growth after liver transplantation. J Pediatr Endocrinol Metab 2004, 17:1097-1103.
15. Lykavieris P, van Mil S, Cresteil D, et al.: Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: no catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation. J Hepatol 2003, 39:447-452.
16. Diem HVT, Sokal EM, Janssen M, et al.: Steroid withdrawal after pediatric liver transplantation: a long-term follow-up study in 109 recipients. Transplantation 2003, 75:1664-1670.
17. Leung Liu C, Tat Fan S, Mau Lo C, et al.: Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage. Liver Transpl 2004, 10:728-733
18. Ganschow R, Grabhorn E, Schulz A, et al.: Long-term results of basiliximab induction immunosuppression in pediatric liver transplant recipients. Pediatr Transplant 2005, 9:741-745.
19. Rodeck B. Kardorff R, Melter M, et al.: Improvement of growth after growth hormone treatment in children who undergo liver transplantation. J Pediatr Gastroenterol Nutr 2000, 31:286-290.
20. Puustinen L, Jalanko H, Holmberg C, et al.: Recombinant human growth hormone treatment after liver transplantation in childhood: the 5-year outcome. Transplantation 2005, 79:1241-1246.
21. Taylor R, Franck LS, Gibson F, et al.: A critical review of the health related quality of life of children and adolescents after liver transplantation. Liver Transpl 2005, 11:51-60.
22. Bucuvalas J, Britto M, Krug S, et al.: Health-related quality of life in pediatric liver transplant recipients: a single-center study. Liver Transpl 2003, 9:62-71.
23. Kennard B, Stewart S, Phelan-McAuliffe D, et al.: Academic outcome in long-term survivors of pediatric liver transplantation. J Dev Behav Pediatr 1999, 20:17-23.
24. Kaller T, Schulz K, Sander K, et al.: Cognitive abilities in children after liver transplantation. Transplantation 2005, 79:1252-1256.
25. Grabhorn E, Schulz A, Helmke K, et al.: Short- and long-term results of liver transplantation in infants aged less than 6 months. Transplantation 2004, 78:235-241.
26. Guthery S, Pohl J, Bucuvalas J, et al.: Bone mineral density in long-term survivors following pediatric liver transplantation. Liver Transpl 2003, 9:365-370.
27. D'Antiga L, Ballan D, Luisetto G, et al.: Long-term outcome of bone mineral density in children who underwent a successful liver transplantation. Transplantation 2004, 78:899-903.
28. Helenius I, Jalanko H, Remes V, et al.: Scoliosis after solid organ transplantation in children and adolescents. Am J Transpl 2006, 6:324-330.
29. Cohen AJ, Stegall M, Rosen C, et al.: Chronic renal dysfunction late after liver transplantation. Liver Transpl 2002, 8:916-921.
30. Samyn M, Cheeseman P, Bevis L, et al.: Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation. Liver Transpl 2005, 11:344-349.
31. Campbell K, Yazigi N, Ryckman F, et al.: High prevalence of renal dysfunction in long-term survivors after pediatric liver transplantation. J Pediatr 2006, 148:475-480.
32. Mention K, Lahoche-Manucci A, Bonnevalle M, et al.: Renal function outcome in pediatric liver transplant recipients. Pediatr Transpl 2005, 9:201-207.
33. Avitzur Y, De Luca E, Cantos M, et al.: Health status ten years after pediatric liver transplantation - looking beyond the graft. Transplantation 2004, 78:566-573.
34. Ferraris JR, Duca P, Prigoshin N, et al.: Mycophenolate mofetil and reduced doses of cyclosporine in pediatric liver transplantation with chronic renal dysfunction: changes in the immune response. Pediatr Transplant 2004, 8:454-459.
35. Evans HM, McKiernan PJ, Kelly DA: Mycophenolate mofetil for renal dysfunction after pediatric liver transplantation. Transplantation 2005, 79:1575-1580.
36. Herzog D, Martin S, Turpin S, et al.: Normal glomerular filtration rate in long-term follow-up of children after orthotopic liver transplantation. Transplantation 2006, 81:672-677./
37. Seifeldin R, Marcos-Alvarez A, Lewis WD, et al.: Effect of nifedipine on renal function in liver transplant recipients receiving tacrolimus. Clin Ther 1996, 18:491-496.
38. Evans H, Kelly DA, McKiernan PJ, et al.: Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology 2006, 43:1109-1117.
39. Martin S, Russo P, Dubois J, et al.: Centrilobular fibrosis in long-term follow-up of pediatric liver transplant recipients. Transplantation 2002, 74:828-836.
40. Riva S, Sonzogni A, Bravi M, et al.: Late graft dysfunction and autoantibodies after liver transplantation in children: preliminary results of an Italian experience. Liver Transpl 2006, 12:573-577.
41. Jain A, Mazariegos G, Pokharna R, et al.: The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis. Transplantation 2003, 75:1020-1025.
42. Hernandez H, Kovarik P, Whitington P, et al.: Autoimmune hepatitis as a late complication of liver transplantation. J Pediatr Gastroenterol Nutr 2001, 32:131-136.
43. Andries S, Casamayou L, Sempous C, et al.: Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine. Transplantation 2001, 72:267-272.
44. Heneghan MA, Portmann B, Norris SM, et al.: Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults. Hepatology 2001, 34:464-470.
45. Vergani D, Mieli-Vergani G: Autoimmunity after liver transplantation. Hepatology 2002, 36:271-276.
46. Aguilera I, Sousa JM, Gavilan F, et al.: Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation. Liver Transpl 2004, 10:1166-1172.
47. Gibelli NE, Tannuri U, Mello ES, et al.: Successful treatment of de novo autoimmune hepatitis and cirrhosis after pediatric liver transplantation. Pediatr Transplant 2006, 10:371-376.
48. Kerkar N, Dugan C, Rumbo C, et al.: Rapamycin successfully treats post-transplant autoimmune hepatitis. Am J Transpl 2005, 5:1085-1089.
49. Lerut J, Sanchez-Fueyo A: An appraisal of tolerance in liver transplantation. Am J Transpl 2006, 6:1774-1780.
50. Girlanda R, Rela M, Williams R, et al.: Long-term outcome of immunosuppression withdrawal after liver transplantation. Transpl Proc 2005, 37:1708-1709.